U01.05.008 Receptor binding

Understanding receptor pharmacology is key to predicting drug effects and answering Step 1 pharmacology questions. Drugs can act as agonists, antagonists, partial agonists, or inverse agonists, each with distinct effects on potency and efficacy.


Key Concepts

  • Efficacy (Emax): The Maximum effect a drug can produce.
  • Potency (EC50): Amount of drug required to produce a given effect.
  • Competitive antagonists shift the dose–response curve to the right (↓ potency, same efficacy).
  • Noncompetitive antagonists lower the efficacy but do not change potency.
  • Partial agonists have lower efficacy than full agonists, even at high doses.
  • Inverse agonists bind the same receptor but decrease baseline activity.

Graphical Summary

  1. Competitive Antagonist → Rightward shift (↓ potency, efficacy unchanged).Competitiove antagonism
  2. Noncompetitive Antagonist → Downward shift (↓ efficacy, potency unchanged).
  3. Partial Agonist → Reduced efficacy compared to a full agonist.
  4. Inverse Agonist → Decreases receptor activity below baseline.

Comparison Table

Type Potency Efficacy Mechanism / Remark Example
Competitive Antagonist ↓ (reduced) ↔ (unchanged) The effect can be overcome by ↑ increasing the agonist concentration Diazepam (agonist) + Flumazenil (competitive antagonist) at GABA<sub>A</sub> receptor
Noncompetitive Antagonist ↔ (unchanged) ↓ (reduced) Cannot be overcome by ↑ an agonist Norepinephrine (agonist) + Phenoxybenzamine (noncompetitive antagonist) at α-receptors
Partial Agonist Independent ↓ (lower than a full agonist) Acts at the same receptor site, but produces a weaker response Morphine (full agonist) vs Buprenorphine (partial agonist) at μ-opioid receptor
Inverse Agonist Independent Independent (reduces baseline activity) Binds constitutively active receptor → opposite effect of agonist H1 antihistamines (eg, Diphenhydramine)

Learning Objective :

Be able to differentiate between competitive antagonists, noncompetitive antagonists, partial agonists, and inverse agonists by recognizing their effects on potency and efficacy and applying this knowledge to clinical drug examples.


Discover more from mymedschool.org

Subscribe to get the latest posts sent to your email.